These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28923913)

  • 1. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
    Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
    J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-23b Targets Ras GTPase-Activating Protein SH3 Domain-Binding Protein 2 to Alleviate Fibrosis and Albuminuria in Diabetic Nephropathy.
    Zhao B; Li H; Liu J; Han P; Zhang C; Bai H; Yuan X; Wang X; Li L; Ma H; Jin X; Chu Y
    J Am Soc Nephrol; 2016 Sep; 27(9):2597-608. PubMed ID: 26839366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
    Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
    Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice.
    Kölling M; Kaucsar T; Schauerte C; Hübner A; Dettling A; Park JK; Busch M; Wulff X; Meier M; Scherf K; Bukosza N; Szénási G; Godó M; Sharma A; Heuser M; Hamar P; Bang C; Haller H; Thum T; Lorenzen JM
    Mol Ther; 2017 Jan; 25(1):165-180. PubMed ID: 28129112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice.
    Hathaway CK; Gasim AM; Grant R; Chang AS; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
    Proc Natl Acad Sci U S A; 2015 May; 112(18):5815-20. PubMed ID: 25902541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
    Deb DK; Sun T; Wong KE; Zhang Z; Ning G; Zhang Y; Kong J; Shi H; Chang A; Li YC
    Kidney Int; 2010 Jun; 77(11):1000-9. PubMed ID: 20182412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.
    Long J; Wang Y; Wang W; Chang BH; Danesh FR
    J Biol Chem; 2011 Apr; 286(13):11837-48. PubMed ID: 21310958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
    Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
    Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
    Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
    J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of miR-34a alleviates mesangial proliferation in vitro and glomerular hypertrophy in early diabetic nephropathy mice by targeting GAS1.
    Zhang L; He S; Guo S; Xie W; Xin R; Yu H; Yang F; Qiu J; Zhang D; Zhou S; Zhang K
    J Diabetes Complications; 2014; 28(3):259-64. PubMed ID: 24560136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 in glomerular injury.
    Lai JY; Luo J; O'Connor C; Jing X; Nair V; Ju W; Randolph A; Ben-Dov IZ; Matar RN; Briskin D; Zavadil J; Nelson RG; Tuschl T; Brosius FC; Kretzler M; Bitzer M
    J Am Soc Nephrol; 2015 Apr; 26(4):805-16. PubMed ID: 25145934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.
    Zhong X; Chung AC; Chen HY; Dong Y; Meng XM; Li R; Yang W; Hou FF; Lan HY
    Diabetologia; 2013 Mar; 56(3):663-74. PubMed ID: 23292313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
    Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
    Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
    J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in microRNA-25 expression regulate cardiac function via renin secretion.
    Li H; Xie Y; Liu Y; Qi Y; Tang C; Li X; Zuo K; Sun D; Shen Y; Pang D; Chu Y; Zhao B
    Exp Cell Res; 2018 Apr; 365(1):119-128. PubMed ID: 29499204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.
    Han F; Wang S; Chang Y; Li C; Yang J; Han Z; Chang B; Sun B; Chen L
    J Cell Physiol; 2018 Mar; 233(3):2225-2237. PubMed ID: 28695984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
    J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.